Evidence suggests that ADO derived by different sources can have distinct functions in cancer cells through either canonical adenosine receptor-mediated pathways (A1, A2A, A2B and A3 AR), or receptor-independent intrinsic mechanisms such as the activation of AMP-dependent protein kinase (AMPK) [69,70], based on ADO concentration. The gene discussed is ADO; the disease is cancer.